We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-13.54%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$1.83B
AUM Growth
-$332M
Cap. Flow
-$24.8M
Cap. Flow %
-1.35%
Top 10 Hldgs %
18.11%
Holding
3,058
New
40
Increased
272
Reduced
460
Closed
69

Top Buys

Rank Stock Value
1
AMLP icon
Alerian MLP ETF
AMLP
+$15.2M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.71M
3
MUB icon
iShares National Muni Bond ETF
MUB
+$3.46M
4
SWK icon
Stanley Black & Decker
SWK
+$3.04M
5
WFC.PRL icon
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
+$2.43M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$4.16M
2
EGN
Energen
EGN
+$3.33M
3
LW icon
Lamb Weston
LW
+$3.12M
4
KEYS icon
Keysight
KEYS
+$3.12M
5
JKHY icon
Jack Henry & Associates
JKHY
+$3.05M

Sector Composition

Rank Sector Weight
1 Technology 13.37%
2 Financials 12.11%
3 Industrials 9.9%
4 Healthcare 9.85%
5 Consumer Discretionary 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRD.B icon
2726
Crawford & Co Class B
CRD.B
$582M
$8K ﹤0.01%
933
– –
FSFG
2727
DELISTED
First Savings Financial Group
FSFG
$8K ﹤0.01%
450
– –
GYRE icon
2728
Gyre Therapeutics
GYRE
$705M
$8K ﹤0.01%
132
– –
LQDA icon
2729
Liquidia Corp
LQDA
$6.76B
$8K ﹤0.01%
390
– –
NATR icon
2730
Nature's Sunshine
NATR
$278M
$8K ﹤0.01%
1,018
– –
OCUL icon
2731
Ocular Therapeutix
OCUL
$2.22B
$8K ﹤0.01%
1,979
– –
OPTN
2732
DELISTED
OptiNose
OPTN
$8K ﹤0.01%
86
– –
QTRX icon
2733
Quanterix
QTRX
$141M
$8K ﹤0.01%
420
– –
RMTI icon
2734
Rockwell Medical
RMTI
$29.5M
$8K ﹤0.01%
32
– –
SB icon
2735
Safe Bulkers
SB
$777M
$8K ﹤0.01%
4,225
– –
XLU icon
2736
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
$8K ﹤0.01%
320
– –
TECX
2737
Tectonic Therapeutic
TECX
$684M
$8K ﹤0.01%
42
– –
PVLA
2738
Palvella Therapeutics
PVLA
$2.25B
$8K ﹤0.01%
38
– –
VIVS
2739
VivoSim Labs
VIVS
$1.16M
$8K ﹤0.01%
34
– –
SCWX
2740
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$8K ﹤0.01%
472
– –
ITI
2741
DELISTED
Iteris, Inc.
ITI
$8K ﹤0.01%
2,069
– –
TPHS
2742
DELISTED
Trinity Place Holdings Inc.com
TPHS
$8K ﹤0.01%
1,859
– –
TTOO
2743
DELISTED
T2 Biosystems, Inc
TTOO
$8K ﹤0.01%
1
– –
VIA
2744
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$8K ﹤0.01%
202
– –
SCTL
2745
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$8K ﹤0.01%
1,334
– –
VAPO
2746
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$8K ﹤0.01%
+48
New +$6.92K
HYLD
2747
DELISTED
High Yield ETF
HYLD
$8K ﹤0.01%
250
– –
ODT
2748
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$8K ﹤0.01%
570
– –
BXG
2749
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$8K ﹤0.01%
637
– –
ARA
2750
DELISTED
American Renal Associates Holdings, Inc
ARA
$8K ﹤0.01%
680
– –
108 109
110
111 112

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return

Ameritas Investment Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Ameritas Investment Partners held 3,058 positions worth $1.83B, down 15% from $2.17B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 3.6%. Ameritas Investment Partners opened 40 new positions and exited 69, leaving the 3,058-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.

  • Ameritas Investment Partners's largest Q4 2018 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 1,920 shares worth $2.42M.
  • Ameritas Investment Partners added most to Alerian MLP ETF in Q4 2018, an estimated $15.2M increase.
  • Ameritas Investment Partners's biggest Q4 2018 reduction was Lamb Weston, cutting an estimated $3.12M.
  • Ameritas Investment Partners fully exited Praxair Inc in Q4 2018, selling an estimated $4.16M.
  • Ameritas Investment Partners's ten largest holdings make up 18% of its $1.83B portfolio in Q4 2018.
  • Ameritas Investment Partners opened 40 new positions and closed 69 in Q4 2018.
  • Ameritas Investment Partners's portfolio value fell 15% quarter-over-quarter to $1.83B.

Based on Ameritas Investment Partners's 13F filing for Q4 2018, filed 12 Feb 2019.